Title |
A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial
|
---|---|
Published in |
Trials, August 2020
|
DOI | 10.1186/s13063-020-04593-8 |
Pubmed ID | |
Authors |
Timothy S. C. Hinks, Vicki S. Barber, Joanna Black, Susan J. Dutton, Maisha Jabeen, James Melhorn, Najib M Rahman, Duncan Richards, Daniel Lasserson, Ian D. Pavord, Mona Bafadhel |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 207 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 207 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 30 | 14% |
Student > Master | 20 | 10% |
Other | 18 | 9% |
Researcher | 17 | 8% |
Student > Ph. D. Student | 13 | 6% |
Other | 26 | 13% |
Unknown | 83 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 56 | 27% |
Nursing and Health Professions | 19 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 14 | 7% |
Biochemistry, Genetics and Molecular Biology | 7 | 3% |
Engineering | 5 | 2% |
Other | 17 | 8% |
Unknown | 89 | 43% |